CS258203B1 - Method of animal albumin insulation - Google Patents
Method of animal albumin insulation Download PDFInfo
- Publication number
- CS258203B1 CS258203B1 CS851035A CS103585A CS258203B1 CS 258203 B1 CS258203 B1 CS 258203B1 CS 851035 A CS851035 A CS 851035A CS 103585 A CS103585 A CS 103585A CS 258203 B1 CS258203 B1 CS 258203B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- albumin
- solution
- adjusted
- added
- supernatant
- Prior art date
Links
Landscapes
- Peptides Or Proteins (AREA)
Abstract
Riešinie možno použiť v imunologicko-biologickej výrobě veterinárnych liečebných prípravkov. Očelom je zavedenie do výroby novej technologie spósobu izolácie zvieracieho albuminu, pri ktorej je zachovaná nativita bielkoviny a dosahovaná vyššia výtažnosť oproti súčasnému stavu poznania. Uvedený izolačný postup představuje iba jeden operačný stupeň a může byť vykonaný pri izbovej teplote. Zjednodušenie izolačného postupu sa dosahuje tým, že krvná plazma, resp. sérum sa stabilizuje N-acetyl-DL-tryptofánom a Na-kaprylátom, pH sa upraví na hodnotu 6,0 až 6,1 a přidá sa 96 % etanol v množstve 12 až 18 objemových percent. Nasledujúcim zahriatím roztoku pri 45 až 55 °C a úpravou hodnoty pH na 5,0 až 5,1 vzniklý precipitát sa odstráni a supernatant představuje albumin minimálně o 95 % elektroforetickej čistotě.The solution can be used in immuno-biological production of veterinary medicinal products. The aim is to introduce a new production Animal albumin isolation technology at which protein nativity is maintained and higher yields compared to current state of knowledge. Said insulating the procedure represents only one operating stage and can be carried out at room temperature. simplification isolation process is achieved by that blood plasma, respectively. the serum stabilizes N-acetyl-DL-tryptophan and Na-caprylate, pH is adjusted to 6.0 to 6.1 and added 96% ethanol in an amount of 12 to 18 vol percent. Subsequent heating of the solution at 45 to 55 ° C and pH adjustment to 5.0 to The precipitate formed is removed and the supernatant is removed represents at least 95% albumin electrophoretic purity.
Description
Vynález sa týká spósobu izolácie zvieracieho albuminu.The invention relates to a process for the isolation of animal albumin.
Doteraz v priemyselnom měřítku zvierací albumin z plazmy alebo séra sa izoloval bud vysolovaním vhodnými solami alebo frakciou organických rozpúšťadiel najma etanolom (Cohn E. J. et al.: J. Amer. Chem. Soc., 68, 459 (1946); Nitschmann H. et al.: Helv. Chim. Acta,To date, on an industrial scale, animal albumin from plasma or serum has been isolated either by salting out with suitable salts or a fraction of organic solvents, in particular ethanol (Cohn EJ et al .: J. Amer. Chem. Soc., 68, 459 (1946); Nitschmann H. et al. Helv Chim Acta
37, 866 (1954)). Nevýhodou uvedených technologických postupov je dlhý technologický cyklus, energetická náročnost a náročné technologické zariadenia. Známe sú tiež tepelno-denaturačné metody izolácie albuminu (Hoch H., Chanutin: Arch. of Biochem. and Biophys., 51, 27, 1954; Lundblad J. I.: Vox sang., 5 122, 1971; Schneider W. et al.: Folia haematol., 104, 116,37, 866 (1954). The disadvantages of the mentioned technological procedures are long technological cycle, energy intensity and demanding technological equipment. Thermal denaturation methods for albumin isolation are also known (Hoch H., Chanutin: Arch. Of Biochem. And Biophys., 51, 27, 1954; Lundblad JI: Vox sang., 5,122, 1971; Schneider W. et al .: Folia haematol.
1977).1977).
Avšak nevýhoda týchto je v tom, že balastné bielkoviny sú denaturované pri vysokých teplotách (+70 °C), čo má nepriaznivý vplyv na nativitu a výtažnosť albuminu. Taktiež izolácia albuminu pri výrobě Plazbionu vychádza zo supernatantu po oddělení imunoglobulínov, využívá taktiež poměrně vysokú denaturačnú teplotu (60 °C) a dlhú dobu denaturácie balastných bielkovín (dve hodiny) a napokon dosahuje poměrně nízku elektroforetickú čistotu (max.However, the disadvantage of these is that the ballast proteins are denatured at high temperatures (+ 70 ° C), which adversely affects the native and yield of albumin. Also, the isolation of albumin in the production of Plazbion is based on the supernatant after separation of immunoglobulins, it also uses a relatively high denaturation temperature (60 ° C) and a long period of denaturation of the ballast proteins (two hours) and finally achieves a relatively low electrophoretic purity (max.
%) a výťažnosť konečného výrobku.%) and the yield of the final product.
Vynález rieši izoláciu albuminu zo zvieracej plazmy, resp. séra jednostupftovým technologickým úkonom, pri ktorom dochádza k denaturácii všetkých plazmatických bielkovín mimo albuminu. Přednost uvedeného postupu oproti doteraz používaným je v tom, že mimo skrátenia výrobného cyklu a nižšej denaturačnej teploty sa dosahuje výťažnosť cca o 30 % vyššia.The invention provides for the isolation of albumin from animal plasma, respectively. sera by a single-step technological procedure in which all plasma proteins except albumin are denatured. The advantage of this process over the hitherto used is that in addition to shortening the production cycle and lower denaturation temperature, the yield is about 30% higher.
Podstata izolácie zvieracieho albuminu spočívá v tom, že ku krvnej plazme, resp. séru sa přidá 0,04 M Na-kaprylátu a 0,04 M N-acetyl-DL-tryptofánu. Po dfikladnej homogenizácii sa hodnota pH upraví 1 M kyselinou octovou na hodnotu 6,0 až 6,1. Za stálého miešania sa po kvapkách přidává 96% etanol do koncentrácie 12 až 18 objemových percent. Potom sa roztok za stálého miešania zahrieva pri teplote 45 až 55 UC po dobu 10 minút. Nato pH zmesi sa upraví na hodnotu 5,0 až 5,1 a schladí na teplotu +18 až +20 °C. Vzniklý preoipitát sa odstředí a supernatant sa filtruje a lyofilizuje.The essence of the isolation of animal albumin is that the blood plasma, respectively. 0.04 M Na-caprylate and 0.04 M N-acetyl-DL-tryptophan are added to the serum. After thorough homogenization, the pH was adjusted to 6.0-6.1 with 1M acetic acid. While stirring, 96% ethanol is added dropwise to a concentration of 12-18% by volume. The solution was stirred with continued heating at 45 to 55 C. In a period of 10 minutes. The pH of the mixture was adjusted to 5.0-5.1 and cooled to +18 to +20 ° C. The resulting pre-precipitate is centrifuged and the supernatant is filtered and lyophilized.
Přiklad č. 1Example no. 1
K 3 800 ml hovSdzej plazmy bol přidaný stabilizátor do výslednéj koncentrácie 0,04 M Na-kaprylátu a 0,04 M N-acetyl-Dl-tryptofánu a pH upravené 1 M kyselinou octovou na pH 6,0.To 3800 ml bovine plasma, a stabilizer was added to a final concentration of 0.04 M Na-caprylate and 0.04 M N-acetyl-D1-tryptophan and adjusted to pH 6.0 with 1 M acetic acid.
K zmesi za stálého miešania bol přidaný 96% etanol v množstve 720 ml a roztok bol zohrievaný pri teplote 45 °C po dobu 10 minút. Potom pH roztoku bolo upravené 1 M kyselinou octovou na hodnotu 5,1 a následné roztok bol schladený na teplotu 18 °C. Vzniklý preoipitát bol separovaný na centrifúge. Supernatant bol filtrovaný a lyofilizovaný. Váha lyofilizovaného produktu 72 g, elektrorofetická čistota 95,8.To the mixture with stirring was added 96% ethanol in an amount of 720 ml and the solution was heated at 45 ° C for 10 minutes. Then the pH of the solution was adjusted to 5.1 with 1M acetic acid and the subsequent solution was cooled to 18 ° C. The resulting pre-precipitate was separated on a centrifuge. The supernatant was filtered and lyophilized. Weight of lyophilized product 72 g, electrophoretic purity 95.8.
Příklad č. 2Example # 2
K 3 800 ml hovSdzej plazmy bol přidaný stabilizátor do výslednéj koncentrácie 0,04 M Na-kaprylátu a 0,04 M N-acetyl-Dl-tryptofánu a pH upravené 1 M kyselinou octovou na 6,1.To 3800 ml of bovine plasma, a stabilizer was added to a final concentration of 0.04 M Na-caprylate and 0.04 M N-acetyl-D1-tryptophan and the pH adjusted to 6.1 with 1 M acetic acid.
£ zmesi za stálého miešania bol přidaný 96% etanol v množstve 480 ml a roztok bol zohrievaný pri teplote 55 °C po dobu 10 minút. Potom pH roztoku bolo upravené 1M kyselinou octovou na hodnotu 5,1 a následné roztok bol oohladený na teplotu 20 °C. Vzniklý preoipitát bol separovaný na centrifúge. Supernatant bol filtrovaný a lyofilizovaný. Váha lyofilizovaného produktu 68 g, elektroforetioká čistota 96,1.96% Ethanol (480 ml) was added with stirring, and the solution was heated at 55 ° C for 10 minutes. Then the pH of the solution was adjusted to 5.1 with 1M acetic acid and the subsequent solution was cooled to 20 ° C. The resulting pre-precipitate was separated on a centrifuge. The supernatant was filtered and lyophilized. Weight of lyophilized product 68 g, electrophoretic purity 96.1.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS851035A CS258203B1 (en) | 1985-02-14 | 1985-02-14 | Method of animal albumin insulation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS851035A CS258203B1 (en) | 1985-02-14 | 1985-02-14 | Method of animal albumin insulation |
Publications (2)
Publication Number | Publication Date |
---|---|
CS103585A1 CS103585A1 (en) | 1987-09-17 |
CS258203B1 true CS258203B1 (en) | 1988-07-15 |
Family
ID=5343717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS851035A CS258203B1 (en) | 1985-02-14 | 1985-02-14 | Method of animal albumin insulation |
Country Status (1)
Country | Link |
---|---|
CS (1) | CS258203B1 (en) |
-
1985
- 1985-02-14 CS CS851035A patent/CS258203B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CS103585A1 (en) | 1987-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4228154A (en) | Purification of plasma albumin by ion exchange chromatography | |
DE69019074T2 (en) | Process for the fractionation of plasma proteins. | |
FI60400C (en) | FOERFARANDE FOER UTVINNING AV ALBUMIN UR BLODPLASMA | |
US7879331B2 (en) | Ultra-high yield intravenous immune globulin preparation | |
US9339530B2 (en) | Process for separating proteins fibrinogen, factor XIII and biological glue from a solubilized plasma fraction and for preparing lyophilised concentrates of said proteins | |
NO168449B (en) | MEASURING TRANSFORMER IN A HIGH VOLTAGE SWITCH | |
JPS6267032A (en) | Collection of recombined human beta-interferon | |
EP0315650B1 (en) | Purification of recombinant interleukin-1 | |
US4301064A (en) | Ubiquitary tissue protein PP8 | |
CA2018511C (en) | Process for the preparation of purified albumin solutions | |
DK148633B (en) | PROCEDURE FOR PREPARING THE INSOLABLE GLOBULIN (CIG) IN THE COLD | |
US4348315A (en) | Process in purification and concentration of the factor VIII-complex | |
Schmid et al. | Partial characterization of the sialic acid-free forms of α1-acid glycoprotein from human plasma | |
CZ303144B6 (en) | Process for preparing recombinant human Chorionic Gonadotropin | |
Poulik et al. | Heterogeneity of H chains of myeloma proteins: susceptibility to papain and trypsin | |
CS258203B1 (en) | Method of animal albumin insulation | |
Liu et al. | Optimization of the culture medium for recombinant protein production under the control of the αAmy3 promoter in a rice suspension-cultured cell expression system | |
US4371462A (en) | Method for purification of anterior pituitary hormones | |
EP0470086B1 (en) | Process for the purification of hemin, a novel hemin derivative and a process for its preparation | |
US4452893A (en) | Cell growth medium supplement | |
Michon | Preparation of Orosomucoid (α1-Acid Seromucoid) | |
EP0359438A1 (en) | Pyridazinone manufacture | |
CZ287035B6 (en) | Process for preparing soluble recombinant proteins from bacterial cells | |
CS269556B1 (en) | Method of albumin insulation | |
Bennich et al. | A phosphopeptide isolated from bovine a-casein after tryptic hydrolysis |